Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioDelivery Sciences rallies 133% to $1.96 after signing deal with Endo
Yahoo/Fly on the Wall
Friday, January 6, 2012 - 10:00am
tags:
Endo, BioDelivery Sciences
Couple says defective recalled Children's Tylenol killed 2-year-old son; J&J disputes that
Yahoo/AP
Friday, January 6, 2012 - 9:59am
tags:
JNJ, recalls, Tylenol
Targacept: Alzheimer's drug studies will continue
Yahoo/AP
Thursday, January 5, 2012 - 1:56pm
tags:
Targacept, Alzheimer's disease, AZD1446, AstraZeneca
XOMA to eliminate 34% of personnel, take one-time charges of $6M
Yahoo/Fly on the Wall
Thursday, January 5, 2012 - 1:11pm
tags:
Xoma, layoffs, reorganization
InterMune's Esbriet rings up $2.8 million in sales since mid-September launch in Germany
Yahoo/AP
Thursday, January 5, 2012 - 1:01pm
tags:
Esbriet, InterMune, IPF, idiopathic pulmonary fibrosis, Germany
Dendreon Surges After Fourth-Quarter Product Revenue Triples
Bloomberg Businessweek
Thursday, January 5, 2012 - 12:45pm
tags:
Dendreon, earnings, Provenge
Will Amgen Buy Out Biogen Idec?
Seeking Alpha
Thursday, January 5, 2012 - 12:39pm
tags:
Biogen Idec, Amgen, M&A
Galena Biopharma announces FDA approves IND application
Yahoo/Fly on the Wall
Thursday, January 5, 2012 - 12:38pm
tags:
Galena Biopharma, FDA, NeuVax, Herceptin, Roche
Buy Celgene As Markets, Revenues, And Earnings Expand
Seeking Alpha
Thursday, January 5, 2012 - 12:35pm
tags:
Celgene
Let Pfizer Compete in the Generic Market with Lipitor
Pharmareform
Thursday, January 5, 2012 - 12:34pm
tags:
generics, Pfizer, Lipitor
Drug Approvals Hit a Seven-Year High in 2011 on Improved Data
Bloomberg
Thursday, January 5, 2012 - 12:27pm
tags:
drug approvals
Merck CEO: This year will be better than 2011
Yahoo/AP
Thursday, January 5, 2012 - 12:26pm
tags:
Merck, Kenneth Frazier, Pharma CEOs
Ista Pharma expects greater income, sales in 2012
Yahoo/AP
Thursday, January 5, 2012 - 12:25pm
tags:
Ista, guidance
Lilly’s 2012 Forecast Misses Analysts’ Estimates
Bloomberg
Thursday, January 5, 2012 - 10:04am
tags:
Eli Lilly, guidance
Pfizer In A Post-Lipitor World: Worth Buying On Dips
Seeking Alpha
Thursday, January 5, 2012 - 10:03am
tags:
Pfizer, Lipitor, patents, vaccines, Celebrex, Pristiq
Jazz Shares Gain Most in More Than 3 Months on Financial Expectations
Bloomberg
Thursday, January 5, 2012 - 10:01am
tags:
Xyrem, Jazz Pharmaceuticals, Azur Pharma
Osiris' Update on Prochymal
Yahoo/Zacks
Thursday, January 5, 2012 - 10:01am
tags:
Osiris, Prochymal, stem cells, type 1 diabetes
Judge calls off Yaz trial, orders suits into mediation
Fierce Pharma
Wednesday, January 4, 2012 - 3:15pm
tags:
Bayer, Yaz, Yasmin, birth control pill
Inhibitex Shares Whipsawed by Cautious Analyst Comment
TheStreet.com
Wednesday, January 4, 2012 - 3:14pm
tags:
Inhibitex, hepatitis C, INX-189
4 Pharma Stocks to Buy & Hold: Najarian
CNBC
Wednesday, January 4, 2012 - 3:13pm
tags:
Merck, Pfizer, Bristol-Myers Squibb, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.